[Federal Register Volume 73, Number 89 (Wednesday, May 7, 2008)]
[Notices]
[Pages 25753-25754]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-10011]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Office of 
Biotechnology Activities; Recombinant DNA Research; Notice of a Meeting 
of an NIH Blue Ribbon Panel

    There will be a meeting of the NIH Blue Ribbon Panel to advise on 
the Risk Assessment of the National Emerging Infectious Diseases 
Laboratories (NEIDL) at Boston University Medical Center. The meeting 
will be held on Friday, May 16, 2008, at The Commonwealth of 
Massachusetts Bureau of State Office Buildings, State House, Gardner 
Auditorium, 24 Beacon Street, Boston, Massachusetts 02133, from 
approximately 9 a.m. to 12 p.m.
    Discussions will include the charge to the Panel and the process 
and framework for deliberations. There will also be time allotted on 
the agenda for public comment. Sign up for public comment will begin at 
approximately 8 a.m. on May 16, 2008. In the event that time does not 
allow for all those interested to present oral comments, anyone may 
file written comments using the address below.
    To file written comments or for further information concerning this 
meeting contact Ms. Laurie Lewallen, Advisory Committee Coordinator, 
Office of Biotechnology Activities, Office of the Director, National 
Institutes of Health, Mail Stop Code 7985, Bethesda, MD 20892-7985, 
301-496-9838, [email protected]
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed above in 
advance of the meeting. Any interested person may file written comments 
with the panel by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name,

[[Page 25754]]

address, telephone number and when applicable, the business or 
professional affiliation of the interested person.
    An agenda and any additional information for the meeting will be 
posted on the agency's Web site: http://www.nih.gov/about/director/acd/index.htm.
    Background information may be obtained by contacting NIH OBA by e-
mail [email protected]

    Dated: April 29, 2008.
Amy P. Patterson,
Director, Office of Biotechnology Activities.
 [FR Doc. E8-10011 Filed 5-6-08; 8:45 am]
BILLING CODE 4140-01-P